KLK5 overexpression predicts a worse prognosis in various cancers, including cutaneous squamous cell carcinoma, colorectal adenocarcinoma, bladder tumors, and ovarian cancer, acting as an oncogene [35, 36, 37, 38]. This evidence concerns the gene KLK5 and colorectal adenocarcinoma.